Bcl-2 Inhibits the Innate Immune Response during Early Pathogenesis of Murine Congenital Muscular Dystrophy
Author Information
Author(s): Jeudy, Wardrop, Alessi, Dominov
Primary Institution: Boston Biomedical Research Institute
Hypothesis
Does muscle-specific expression of Bcl-2 affect early pathological events in Lama2-deficient muscular dystrophy?
Conclusion
Muscle-specific expression of Bcl-2 reduces early inflammation and alters the innate immune response in Lama2-deficient mice.
Supporting Evidence
- Bcl-2 expression reduced TN-C levels in Lama2-deficient muscles at 7 days of age.
- MyoD-hBcl-2 transgenic mice showed delayed apoptosis in muscle fibers.
- Inflammatory markers were significantly elevated in Lama2-deficient muscles.
- Bcl-2 inhibited the induction of several Toll-like receptors in diseased muscle.
- Eosinophil infiltration was significantly reduced in Bcl-2 transgenic mice.
Takeaway
This study shows that a protein called Bcl-2 can help protect muscles in mice with a specific disease by reducing inflammation and immune response early on.
Methodology
The study used a Lama2-deficient mouse model to analyze inflammation and immune response through quantitative immunohistological and mRNA analyses.
Limitations
The study primarily focuses on early stages of disease and may not reflect later pathological changes.
Participant Demographics
Mice used were Lama2-deficient and transgenic for Bcl-2.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website